{"title":"己胺乙酰丙酸蓝光膀胱镜对非肌肉浸润性膀胱癌(NMIBC)复发和进展的临床影响:一个重要的回顾","authors":"O. Abdalla, S. Sriprasad, S. Madaan","doi":"10.32474/JUNS.2019.01.000123","DOIUrl":null,"url":null,"abstract":"Bladder cancer (BC) is considered as the second most common\nurological malignancy [1] and the eighth most prevalent cancer\nin males and 14th most common malignancy in females","PeriodicalId":438157,"journal":{"name":"Journal of Urology & Nephrology Studies","volume":"191 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Clinical Impact of Hexylaminolevulinate-Blue Light Cystoscopy on Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence and Progression: A Critical Review\",\"authors\":\"O. Abdalla, S. Sriprasad, S. Madaan\",\"doi\":\"10.32474/JUNS.2019.01.000123\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Bladder cancer (BC) is considered as the second most common\\nurological malignancy [1] and the eighth most prevalent cancer\\nin males and 14th most common malignancy in females\",\"PeriodicalId\":438157,\"journal\":{\"name\":\"Journal of Urology & Nephrology Studies\",\"volume\":\"191 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Urology & Nephrology Studies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32474/JUNS.2019.01.000123\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Urology & Nephrology Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32474/JUNS.2019.01.000123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Clinical Impact of Hexylaminolevulinate-Blue Light Cystoscopy on Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence and Progression: A Critical Review
Bladder cancer (BC) is considered as the second most common
urological malignancy [1] and the eighth most prevalent cancer
in males and 14th most common malignancy in females
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
